News

Drug Farm and Xiamen Amoytop Biotech Co., Ltd. to treat hepatitis B and hepatocellular cancer by entering into option agreement.
Drugs that target wakefulness, molecules in cannabis and wearable devices that modulate brain activity could help people with insomnia ...
CCM Biosciences’ novel, orally bioavailable FLT3 inhibitors (CCM-405 and CCM-445) are the first drug candidates to overcome both FLT3-ITD juxtamembrane domain and tyrosine kinase domain (TKD) ...
The most expensive drug category for nonfederal hospitals in 2024 were antineoplastic targeted agents, according to a study published in the American Journal of Health-System Pharmacy. The report ...
Jihye Han: 22:23 Studies have, consistently shown that the majority of new drugs, including first in class drugs, are first launched in The US before any other country.
First-in-class drugs can be highly innovative because of their novel mechanisms of action, but they also carry uncertainty in the absence of clinical experience. To understand how such drugs ...
This review focuses on DRESS, a serious drug-induced T-cell–mediated condition with marked cutaneous and systemic effects.
Medically reviewed by Jeffrey S. Lander, MD There are many types and combinations of drugs used to treat a myocardial infarction (MI), also known as a heart attack. These drugs can help prevent blood ...
The FDA has approved a new drug called zolbetuximab designed to attack a novel target that’s in a type of stomach cancer.
This is the first new class of treatment for the psychiatric disorder since clozapine, the first atypical antipsychotic, was approved in 1989. Cobenfy is a combination of xanomeline and trospium.
Early data from GSK Plc and iTeos Therapeutics’ mid-stage trial of a lung cancer medicine looks set to renew cautious optimism around a class of immunotherapy drugs that has suffered a series of ...
UCSF scientists have discovered how to target a class of molecular switches called GTPases that are involved in a myriad of diseases from Parkinson's to cancer and have long been thought to be ...